Resmed (RMD) EBT (2009 - 2026)

Resmed's EBT history runs 18 years deep, the most recent figure standing at $502.3 million for Q1 2026.

• Quarterly EBT rose 20.26% year-over-year to $502.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 billion (up 20.67% YoY) and the FY2025 annual result came in at $1.7 billion, up 32.64% from the prior year.
• EBT was $502.3 million for Q1 2026 at Resmed, up from $496.1 million in the prior quarter.
• Across five years, EBT topped out at $502.3 million in Q1 2026 and bottomed at $226.3 million in Q1 2022.
• A 5-year average of $350.2 million and a median of $357.7 million in 2024 frame the typical range for EBT.
• Annual changes were most pronounced in 2023 — EBT dropped 5.2% — and 2024, when it jumped 61.23%.
• Resmed's EBT stood at $273.7 million in 2022, then dropped by 5.2% to $259.5 million in 2023, then jumped by 61.23% to $418.3 million in 2024, then gained by 18.6% to $496.1 million in 2025, then increased by 1.24% to $502.3 million in 2026.
• Business Quant data shows RMD's EBT at $502.3 million in Q1 2026, $496.1 million in Q4 2025, and $446.8 million in Q3 2025.